This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Changyou Ma: Innovator in Pharmaceutical Development
Introduction
Changyou Ma is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work has implications for the treatment of diseases mediated by AKT protein kinase.
Latest Patents
Changyou Ma holds a patent for an AKT inhibitor. This invention specifically relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof. The patent also outlines a preparation method and the use of this compound in the prevention and/or treatment of diseases mediated by AKT protein kinase.
Career Highlights
Throughout his career, Changyou Ma has worked with Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. His experience in this company has allowed him to develop innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Jie An and Donghui Chen. Their collaboration has contributed to the advancement of research and development in their field.
Conclusion
Changyou Ma's contributions to pharmaceutical innovation, particularly through his patent on an AKT inhibitor, highlight his role as a key figure in the industry. His work continues to influence the development of treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile